Annual SGA
$17.19 M
+$2.58 M+17.62%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual SGA is $17.19 million, with the most recent change of +$2.58 million (+17.62%) on December 31, 2023.
- During the last 3 years, AVTE annual SGA has risen by +$16.24 million (+1711.38%).
- AVTE annual SGA is now at all-time high.
Performance
AVTE SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$7.08 M
+$2.17 M+44.03%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly SGA is $7.08 million, with the most recent change of +$2.17 million (+44.03%) on September 30, 2024.
- Over the past year, AVTE quarterly SGA has increased by +$2.83 million (+66.52%).
- AVTE quarterly SGA is now at all-time high.
Performance
AVTE Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$789.04 M
-$84.61 M-12.01%
September 30, 2024
Summary
- As of February 8, 2025, AVTE TTM SGA is -$789.04 million, with the most recent change of -$84.61 million (-12.01%) on September 30, 2024.
- Over the past year, AVTE TTM SGA has dropped by -$806.23 million (-4690.12%).
- AVTE TTM SGA is now -5785.29% below its all-time high of -$13.41 million.
Performance
AVTE TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AVTE Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.6% | +66.5% | -4690.1% |
| 3 y3 years | +1711.4% | +66.5% | -4690.1% |
| 5 y5 years | +7785.3% | +66.5% | -4690.1% |
AVTE Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.9% | at high | +119.8% | -668.0% | at low |
| 5 y | 5-year | at high | +7785.3% | at high | +4559.2% | -5785.3% | at low |
| alltime | all time | at high | +7785.3% | at high | +4559.2% | -5785.3% | at low |
Aerovate Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $7.08 M(+44.0%) | $20.79 M(+14.3%) |
| Jun 2024 | - | $4.92 M(+8.4%) | $18.19 M(+3.5%) |
| Mar 2024 | - | $4.54 M(+6.7%) | $17.58 M(+2.3%) |
| Dec 2023 | $17.19 M(+17.6%) | $4.25 M(-5.2%) | $17.19 M(+3.8%) |
| Sep 2023 | - | $4.48 M(+4.2%) | $16.57 M(+7.2%) |
| Jun 2023 | - | $4.30 M(+3.6%) | $15.45 M(+3.0%) |
| Mar 2023 | - | $4.15 M(+14.3%) | $15.00 M(+2.6%) |
| Dec 2022 | $14.62 M | $3.63 M(+7.8%) | $14.62 M(+2.9%) |
| Sep 2022 | - | $3.37 M(-12.5%) | $14.21 M(+4.3%) |
| Jun 2022 | - | $3.85 M(+2.3%) | $13.62 M(+21.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $3.76 M(+16.8%) | $11.21 M(+39.6%) |
| Dec 2021 | $8.04 M(+746.7%) | $3.22 M(+15.8%) | $8.04 M(+55.1%) |
| Sep 2021 | - | $2.78 M(+92.3%) | $5.18 M(+93.7%) |
| Jun 2021 | - | $1.45 M(+147.8%) | $2.67 M(+93.6%) |
| Mar 2021 | - | $584.00 K(+59.6%) | $1.38 M(+45.5%) |
| Dec 2020 | $949.00 K(+335.3%) | $366.00 K(+32.1%) | $949.00 K(+62.8%) |
| Sep 2020 | - | $277.00 K(+79.9%) | $583.00 K(+90.5%) |
| Jun 2020 | - | $154.00 K(+1.3%) | $306.00 K(+101.3%) |
| Mar 2020 | - | $152.00 K | $152.00 K |
| Dec 2019 | $218.00 K | - | - |
FAQ
- What is Aerovate Therapeutics annual SGA?
- What is the all time high annual SGA for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual SGA year-on-year change?
- What is Aerovate Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly SGA year-on-year change?
- What is Aerovate Therapeutics TTM SGA?
- What is the all time high TTM SGA for Aerovate Therapeutics?
- What is Aerovate Therapeutics TTM SGA year-on-year change?
What is Aerovate Therapeutics annual SGA?
The current annual SGA of AVTE is $17.19 M
What is the all time high annual SGA for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual SGA is $17.19 M
What is Aerovate Therapeutics annual SGA year-on-year change?
Over the past year, AVTE annual SGA has changed by +$2.58 M (+17.62%)
What is Aerovate Therapeutics quarterly SGA?
The current quarterly SGA of AVTE is $7.08 M
What is the all time high quarterly SGA for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly SGA is $7.08 M
What is Aerovate Therapeutics quarterly SGA year-on-year change?
Over the past year, AVTE quarterly SGA has changed by +$2.83 M (+66.52%)
What is Aerovate Therapeutics TTM SGA?
The current TTM SGA of AVTE is -$789.04 M
What is the all time high TTM SGA for Aerovate Therapeutics?
Aerovate Therapeutics all-time high TTM SGA is -$13.41 M
What is Aerovate Therapeutics TTM SGA year-on-year change?
Over the past year, AVTE TTM SGA has changed by -$806.23 M (-4690.12%)